Dr. Scott Arthur Kono, DO

Dr. Kono practices at UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth.

Dr. Kono's NPI, 1184671067, was assigned on May 27, 2006. Dr. Kono graduated from Chicago College of Osteopathic Medicine at Midwestern University in 2003. Dr. Kono holds Colorado license DR.0046803.

Dr. Kono's primary practice is UCHealth University of Colorado Hospital, at 12605 E 16th Ave, Aurora, CO 80045 in Adams County. The practice phone is (720) 848-0000.

Dr. Kono's primary practice is UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth. Dr. Kono is also affiliated with Children's Hospital Colorado Anschutz Medical Campus. The medical group on file is UCHealth Medical Group. Dmand AI also links Dr. Kono to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kono practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Kono's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Kono is board certified in medical oncology by the American Board of Internal Medicine. Dr. Kono is licensed in Colorado.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Kono treats.

CMS data shows 596 Medicare services from Dr. Kono across 5 procedure codes in 2024, for 221 Medicare patients. Medicare paid $67,852 for them. Every service was in an office.

CMS counts 221 Medicare patients who saw Dr. Kono in 2024. The largest group is 65 to 74, with 113 patients. 66% of them have high cholesterol, and 65% have cancer. 8% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kono's median patient age at 72, with 68% women.

In 2024, Dr. Kono wrote 876 Medicare Part D claims for 165 patients. 81% of them were for generic drugs. CMS names the drug for 585 of them, across 21 drugs with 11 or more claims each, at $1,086,372 in total drug cost. In 2023, CMS named 528 claims across 20 drugs.

Dr. Kono accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kono as offering telehealth.

Dmand AI links 27 papers to Dr. Kono, published from 2010 to 2022. 2012 was the busiest year, with 5. The most frequent topics are Carcinoma, Squamous Cell, Head and Neck Neoplasms and Antineoplastic Combined Chemotherapy Protocols. Dr. Kono has published most often in Cancer. Dr. Kono's most frequent co-authors are Nabil F. Saba, MD, Fadlo R. Khuri, MD and Jonathan Jay Beitler, MBA, MD.

Dmand AI links Dr. Kono to 1 clinical trial. Conditions studied include Head and Neck Neoplasms.

CMS Open Payments shows 9 general payments to Dr. Kono from 9 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 89% of the total. Inari Medical, Inc. paid the most, $155.

Dr. Kono graduated from Chicago College of Osteopathic Medicine at Midwestern University in 2003.

Dr. Kono is in network with 15 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.